chr22-50697269-T-TG
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000692848.2(SHANK3):c.1530-295_1530-294insG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00892 in 240,746 control chromosomes in the GnomAD database, including 4 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0059 ( 2 hom., cov: 29)
Exomes 𝑓: 0.013 ( 2 hom. )
Consequence
SHANK3
ENST00000692848.2 intron
ENST00000692848.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.94
Publications
1 publications found
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]
SHANK3 Gene-Disease associations (from GenCC):
- Phelan-McDermid syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- schizophrenia 15Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 22-50697269-T-TG is Benign according to our data. Variant chr22-50697269-T-TG is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 50948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00595 (801/134670) while in subpopulation NFE AF = 0.00839 (524/62482). AF 95% confidence interval is 0.00779. There are 2 homozygotes in GnomAd4. There are 359 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High AC in GnomAd4 at 801 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SHANK3 | NM_001372044.2 | c.1528-280dupG | intron_variant | Intron 12 of 24 | NP_001358973.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SHANK3 | ENST00000692848.2 | c.1530-295_1530-294insG | intron_variant | Intron 11 of 22 | ENSP00000510794.2 | |||||
| SHANK3 | ENST00000262795.8 | c.948-295_948-294insG | intron_variant | Intron 9 of 20 | 5 | ENSP00000489147.3 | ||||
| SHANK3 | ENST00000414786.8 | n.1532-295_1532-294insG | intron_variant | Intron 10 of 21 | 5 | |||||
| SHANK3 | ENST00000673971.3 | n.1530-295_1530-294insG | intron_variant | Intron 11 of 22 | ENSP00000501192.2 |
Frequencies
GnomAD3 genomes AF: 0.00596 AC: 802AN: 134598Hom.: 2 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
802
AN:
134598
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00523 AC: 19AN: 3636 AF XY: 0.00642 show subpopulations
GnomAD2 exomes
AF:
AC:
19
AN:
3636
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0127 AC: 1346AN: 106076Hom.: 2 Cov.: 0 AF XY: 0.0126 AC XY: 678AN XY: 53930 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
1346
AN:
106076
Hom.:
Cov.:
0
AF XY:
AC XY:
678
AN XY:
53930
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
16
AN:
2912
American (AMR)
AF:
AC:
28
AN:
3178
Ashkenazi Jewish (ASJ)
AF:
AC:
58
AN:
3910
East Asian (EAS)
AF:
AC:
3
AN:
10680
South Asian (SAS)
AF:
AC:
6
AN:
1774
European-Finnish (FIN)
AF:
AC:
106
AN:
9912
Middle Eastern (MID)
AF:
AC:
0
AN:
704
European-Non Finnish (NFE)
AF:
AC:
1040
AN:
66100
Other (OTH)
AF:
AC:
89
AN:
6906
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.377
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00595 AC: 801AN: 134670Hom.: 2 Cov.: 29 AF XY: 0.00548 AC XY: 359AN XY: 65452 show subpopulations
GnomAD4 genome
AF:
AC:
801
AN:
134670
Hom.:
Cov.:
29
AF XY:
AC XY:
359
AN XY:
65452
show subpopulations
African (AFR)
AF:
AC:
97
AN:
36006
American (AMR)
AF:
AC:
105
AN:
13594
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
3190
East Asian (EAS)
AF:
AC:
3
AN:
4182
South Asian (SAS)
AF:
AC:
5
AN:
3886
European-Finnish (FIN)
AF:
AC:
28
AN:
8358
Middle Eastern (MID)
AF:
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
AC:
524
AN:
62482
Other (OTH)
AF:
AC:
11
AN:
1868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Sep 13, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 28, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
SHANK3: BS1 -
Jan 08, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Phelan-McDermid syndrome Uncertain:1
Mar 01, 2013
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.